Supplement: WA SB6127 | 2023-2024 | Regular Session | Senate Bill Report (Orig.)

For additional supplements on Washington SB6127 please see the Bill Drafting List
Bill Title: Increasing access to human immunodeficiency virus postexposure prophylaxis drugs or therapies.

Status: 2024-03-25 - Effective date 1/1/2025. [SB6127 Detail]

Download: Washington-2023-SB6127-Senate_Bill_Report_Orig_.pdf
It appears your computer is unable to display this document, however you can Download Washington-2023-SB6127-Senate_Bill_Report_Orig_.pdf here.
feedback